ANNX Q3 2022 Earnings — Annexon, Inc. Revenue & Financial Results | Market Cap Arena

ANNXAnnexon, Inc.

$713M

Q3 2022 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$0

Gross Profit

$0

Operating Income

-$36M

Net Income

-$35M

EPS (Diluted)

$-0.50

QoQ Revenue Growth

NaN%

Cash Flow

Operating Cash Flow

-$31M

Free Cash Flow

-$31M

Stock-Based Comp.

$0

Balance Sheet

Total Assets

$313M

Total Liabilities

$52M

Stockholders' Equity

$261M

Cash & Equivalents

$211M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$0	$0	—
Gross Profit	$0	$0	—
Operating Income	-$36M	-$36M	-1.1%
Net Income	-$35M	-$36M	+1.5%